The European Battery Boom?

From The Gold Letter | Ad

Europe is fighting back against China's stranglehold on lithium. Here's how to profit from it.

Join The Fight Here

MRUS Insider Trading (Merus)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.90%

Insider Buying (Last 12 Months): $37,117,230.62

Insider Selling (Last 12 Months): $45,441,209.50

Merus Insider Trading History Chart

Merus Share Price & Price History

^$17.32

▲ +0.84 (5.10%)

As of 07/28/2021 04:20 PM ET

Days: 30 | 90 | 365

Don't Miss The Burgeoning Lithium Megatrend

From Investing Trends | Ad

By 2025... manufacturers will need 1.1 million tons of lithium. Here's how investors could take advantage of this lithium explosion.

See The Full Report On The Lithium Explosion Now

Merus Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/2/2021	Bvf Partners L P/Il	Major Shareholder	Sell	2,186,022	$20.75	$45,359,956.50
7/1/2021	Lex Bakker	SVP	Sell	3,860	$21.05	$81,253.00
3/22/2021	Bvf Partners L P/Il	Major Shareholder	Buy	79,500	$22.75	$1,808,625.00
3/16/2021	Bvf Partners L P/Il	Major Shareholder	Buy	250,000	$23.00	$5,750,000.00
1/21/2021	Bvf Partners L P/Il	Major Shareholder	Buy	844,680	$24.75	$20,905,830.00
12/18/2020	Bvf Partners L P/Il	Major Shareholder	Buy	160,000	$16.05	$2,568,000.00
9/15/2020	Bvf Partners L P/Il	Major Shareholder	Buy	146,754	$11.75	$1,724,359.50
9/10/2020	Bvf Partners L P/Il	Major Shareholder	Buy	189,651	$11.10	$2,105,126.10
9/3/2020	Bvf Partners L P/Il	Major Shareholder	Buy	201,906	$11.17	$2,255,290.02
7/7/2020	Mark Throsby	EVP	Sell	368	$15.46	$5,689.28	45,515
6/8/2020	Bvf Partners L P/Il	Major Shareholder	Buy	87,254	$15.20	$1,326,260.80
6/1/2020	Bvf Partners L P/Il	Major Shareholder	Buy	1,462,510	$14.00	$20,475,140.00
5/6/2020	Mark Throsby	EVP	Sell	368	$14.54	$5,350.72	44,835
4/2/2020	Mark Throsby	EVP	Sell	368	$10.93	$4,022.24	44,495
3/4/2020	Mark Throsby	EVP	Sell	368	$18.10	$6,660.80	44,155
2/24/2020	Mark Throsby	EVP	Sell	57,088	$17.74	$1,012,741.12	100,903
1/16/2020	Bvf Partners L P/Il	Major Shareholder	Buy	278,730	$16.15	$4,501,489.50
1/13/2020	Value Fund L P Biotechnology	Insider	Buy	83,962	$15.60	$1,309,807.20

Insider Selling at Merus?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Merus and related companies.

SEC Filings (Institutional Ownership Changes) for Merus (NASDAQ:MRUS)

69.69% of Merus stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Merus Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/10/2021	Perceptive Advisors LLC	175,000	$3.66M	0.0%	N/A	0.456%
5/19/2021	Hillhouse Capital Advisors LTD.	46,532	$0.97M	0.0%	-92.2%	0.121%
5/19/2021	Octagon Capital Advisors LP	200,000	$4.18M	1.6%	N/A	0.522%
5/18/2021	BVF Inc. IL	7,285,071	$152.19M	5.7%	+25.5%	18.996%
5/18/2021	Millennium Management LLC	138,595	$2.90M	0.0%	+468.5%	0.361%
5/18/2021	Morgan Stanley	488,325	$10.20M	0.0%	+91.6%	1.273%
5/18/2021	Boxer Capital LLC	1,900,000	$39.69M	1.3%	+33.1%	4.954%
5/18/2021	Citadel Advisors LLC	50,650	$1.06M	0.0%	N/A	0.132%
5/18/2021	Old Well Partners LLC	10,722	$0.22M	0.1%	N/A	0.028%
5/18/2021	Silverarc Capital Management LLC	244,713	$5.11M	2.8%	N/A	0.638%
5/17/2021	Vivo Capital LLC	175,000	$3.66M	0.1%	N/A	0.456%
5/17/2021	PDT Partners LLC	14,281	$0.30M	0.0%	N/A	0.037%
5/17/2021	Perceptive Advisors LLC	175,000	$3.66M	0.0%	N/A	0.456%
5/17/2021	DAFNA Capital Management LLC	157,841	$3.30M	0.8%	N/A	0.412%
5/17/2021	Sphera Funds Management LTD.	76,992	$1.61M	0.1%	N/A	0.201%
5/17/2021	Ikarian Capital LLC	111,223	$2.32M	0.1%	-79.3%	0.290%
5/17/2021	Goldman Sachs Group Inc.	19,563	$0.41M	0.0%	N/A	0.051%
5/14/2021	Credit Suisse AG	19,860	$0.42M	0.0%	+87.1%	0.052%
5/13/2021	Franklin Resources Inc.	175,010	$3.66M	0.0%	N/A	0.456%
5/13/2021	Renaissance Technologies LLC	76,988	$1.61M	0.0%	+210.4%	0.201%
5/13/2021	Federated Hermes Inc.	3,084,257	$64.43M	0.1%	+5.0%	8.042%
5/13/2021	Platinum Investment Management Ltd.	214,974	$4.49M	0.1%	-6.2%	0.561%
5/12/2021	Northern Trust Corp	56,894	$1.19M	0.0%	-19.3%	0.148%
5/12/2021	Geode Capital Management LLC	15,032	$0.31M	0.0%	+26.1%	0.039%
5/12/2021	UBS Group AG	2,899	$61K	0.0%	+214.8%	0.008%
5/7/2021	BlackRock Inc.	79,540	$1.66M	0.0%	+16.3%	0.207%
5/7/2021	Swiss National Bank	50,454	$1.05M	0.0%	+39.6%	0.132%
5/4/2021	Victory Capital Management Inc.	49,960	$1.04M	0.0%	N/A	0.131%
2/16/2021	Morgan Stanley	254,907	$4.47M	0.0%	+62.6%	0.807%
2/12/2021	Opaleye Management Inc.	353,000	$6.19M	0.8%	+176,400.0%	1.117%
2/12/2021	Federated Hermes Inc.	2,936,798	$51.48M	0.1%	+16.3%	9.293%
2/12/2021	Ikarian Capital LLC	536,921	$9.41M	0.4%	N/A	1.699%
2/12/2021	Credit Suisse AG	10,612	$0.19M	0.0%	N/A	0.034%
2/11/2021	Northern Trust Corp	70,472	$1.24M	0.0%	-10.9%	0.223%
2/10/2021	Renaissance Technologies LLC	24,800	$0.44M	0.0%	N/A	0.078%
2/5/2021	BlackRock Inc.	68,384	$1.20M	0.0%	-8.1%	0.216%
11/13/2020	Morgan Stanley	156,766	$1.88M	0.0%	-19.6%	0.539%
11/13/2020	UBS Asset Management Americas Inc.	11,800	$0.14M	0.0%	N/A	0.041%
11/12/2020	Federated Hermes Inc.	2,524,936	$30.30M	0.1%	+3.5%	8.680%
11/10/2020	State Street Corp	26,268	$0.32M	0.0%	+94.9%	0.090%
11/6/2020	BlackRock Inc.	74,391	$0.89M	0.0%	+3.5%	0.256%
11/5/2020	California Public Employees Retirement System	52,700	$0.63M	0.0%	-6.1%	0.181%
11/5/2020	Alps Advisors Inc.	37,047	$0.45M	0.0%	-6.5%	0.128%
11/4/2020	Alps Advisors Inc.	37,047	$0.45M	0.0%	-6.5%	0.128%
10/16/2020	Sanders Morris Harris LLC	24,870	$0.33M	0.1%	N/A	0.086%
9/15/2020	Two Sigma Advisers LP	62,500	$1.01M	0.0%	+45.0%	0.215%
8/14/2020	PDT Partners LLC	11,600	$0.19M	0.0%	N/A	0.040%
8/14/2020	Bank of America Corp DE	2,013	$32K	0.0%	N/A	0.007%
8/14/2020	Artal Group S.A.	384,000	$6.18M	0.2%	-23.2%	1.322%
8/14/2020	BVF Inc. IL	5,090,571	$81.91M	5.0%	+43.6%	17.528%
8/14/2020	Driehaus Capital Management LLC	820,925	$13.21M	0.3%	-39.1%	2.827%
8/13/2020	Sofinnova Investments Inc.	1,311,039	$21.10M	1.3%	-33.1%	4.514%
8/13/2020	Federated Hermes Inc.	2,439,196	$39.25M	0.1%	+34.6%	8.399%
8/13/2020	Old West Investment Management LLC	15,940	$0.26M	0.1%	-34.5%	0.055%
8/13/2020	Athanor Capital LP	46,978	$0.76M	0.0%	+15.1%	0.162%
8/12/2020	Bank of New York Mellon Corp	17,119	$0.28M	0.0%	N/A	0.059%
8/12/2020	California Public Employees Retirement System	56,095	$0.90M	0.0%	+390.3%	0.193%
8/6/2020	Platinum Investment Management Ltd.	190,408	$3.06M	0.1%	-10.5%	0.656%
8/5/2020	Alps Advisors Inc.	39,609	$0.64M	0.0%	-22.6%	0.136%
8/5/2020	Swiss National Bank	36,154	$0.58M	0.0%	N/A	0.124%
5/15/2020	Weiss Multi Strategy Advisers LLC	24,077	$0.29M	0.0%	-3.7%	0.083%
5/15/2020	Morgan Stanley	165,490	$2M	0.0%	+3.8%	0.570%
5/15/2020	Cormorant Asset Management LP	600,000	$7.26M	0.3%	-40.0%	2.066%
5/15/2020	Two Sigma Investments LP	28,584	$0.35M	0.0%	-50.5%	0.098%
5/15/2020	Two Sigma Advisers LP	43,100	$0.52M	0.0%	+9.9%	0.148%
5/15/2020	Driehaus Capital Management LLC	1,348,017	$16.31M	0.5%	-6.0%	4.643%
5/14/2020	Athanor Capital LP	40,822	$0.49M	0.0%	-7.0%	0.141%
5/14/2020	Wellington Management Group LLP	843,483	$10.21M	0.0%	-7.6%	2.908%
5/13/2020	Federated Hermes Inc.	1,812,000	$21.93M	0.1%	+68.2%	6.248%
5/6/2020	Alps Advisors Inc.	51,190	$0.62M	0.0%	-10.4%	0.177%
4/28/2020	Global Retirement Partners LLC	2,603	$31K	0.0%	+62.7%	0.009%
2/18/2020	EcoR1 Capital LLC	1,718,200	$24.19M	2.2%	+937.6%	7.340%
2/14/2020	BVF Inc. IL	3,169,654	$44.63M	3.4%	-31.7%	13.541%
2/14/2020	Marshall Wace LLP	15,896	$0.22M	0.0%	N/A	0.068%
2/14/2020	Marshall Wace North America L.P.	2,404	$34K	0.0%	N/A	0.010%
2/14/2020	UBS Group AG	2,105	$30K	0.0%	N/A	0.009%
2/13/2020	Oxford Asset Management LLP	52,461	$0.74M	0.0%	N/A	0.224%
2/13/2020	Platinum Investment Management Ltd.	170,112	$2.40M	0.0%	+22.3%	0.727%
2/13/2020	Renaissance Technologies LLC	17,200	$0.24M	0.0%	N/A	0.073%
2/12/2020	Driehaus Capital Management LLC	1,434,282	$20.20M	0.5%	+130.4%	6.127%
2/11/2020	Old West Investment Management LLC	26,779	$0.38M	0.1%	N/A	0.114%
2/7/2020	Tower Research Capital LLC TRC	2,049	$29K	0.0%	-23.9%	0.009%
2/6/2020	Acadian Asset Management LLC	12,035	$0.17M	0.0%	+29.5%	0.051%
1/27/2020	California Public Employees Retirement System	11,441	$0.16M	0.0%	+14.4%	0.049%
11/5/2019	Tower Research Capital LLC TRC	2,692	$48K	0.0%	N/A	0.012%
10/30/2019	State of Tennessee Treasury Department	2,047	$36K	0.0%	-35.0%	0.009%
8/14/2019	Morgan Stanley	92,776	$1.36M	0.0%	+3.1%	0.408%
8/14/2019	Novo Holdings A S	495,016	$7.25M	1.0%	-1.5%	2.176%
8/13/2019	Athanor Capital LP	22,785	$0.33M	0.0%	N/A	0.100%
8/10/2019	Artal Group S.A.	350,000	$5.13M	0.2%	+16.7%	1.538%
8/7/2019	Granite Investment Partners LLC	16,851	$0.25M	0.0%	-46.7%	0.074%
8/7/2019	JPMorgan Chase & Co.	8,722	$0.12M	0.0%	+63.5%	0.038%
5/13/2019	Granite Investment Partners LLC	31,645	$0.47M	0.0%	N/A	0.139%
2/14/2019	Squarepoint Ops LLC	11,800	$0.17M	0.0%	+10.3%	0.052%
2/13/2019	RMB Capital Management LLC	24,868	$0.35M	0.0%	-27.3%	0.109%
2/13/2019	Geode Capital Management LLC	14,987	$0.21M	0.0%	+18.8%	0.066%
2/13/2019	Tekla Capital Management LLC	367,671	$5.15M	0.2%	-11.2%	1.616%
2/11/2019	Artal Group S.A.	206,125	$2.89M	0.1%	N/A	0.906%
11/20/2018	Morgan Stanley	71,643	$1.42M	0.0%	+74.3%	0.317%
11/13/2018	Laurion Capital Management LP	106,596	$2.10M	0.0%	N/A	0.471%

Data available starting January 2016

Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trial for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 for the pancreatic and lung cancer, and other solid tumors. The company is also developing MCLA-117 that is in phase I clinical trial for the treatment of patients with acute myeloid leukemia; MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat autoimmune disease. In addition, its research and development stage bispecific antibody candidates include MCLA-129, which is being developed in collaboration with Betta Pharmaceuticals Co. Ltd; MCLA-145, which is being developed in collaboration with Incyte Corporation; and clinical programs to explore potential combination therapies or indication. Merus N.V. has collaborations and license agreement with Loxo Oncology at Lilly to discover and research novel T-cell re-directing bispecific antibodies. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

Today's Range

Now: $17.32

$16.68

$17.39

50 Day Range

MA: $20.49

$16.48

$25.22

52 Week Range

Now: $17.32

$10.18

$31.27

Volume

2,957 shs

Average Volume

207,266 shs

Market Capitalization

$664.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.61

Who are the company insiders with the largest holdings of Merus?

Merus' top insider shareholders include:

Mark Throsby (EVP)
Bvf Partners L P/Il (Major Shareholder)
Lex Bakker (SVP)
Value Fund L P Biotechnology (Insider)

The European Battery Boom?

From The Gold Letter | Ad

Europe is fighting back against China's stranglehold on lithium. Here's how to profit from it.

Join The Fight Here